QR kód

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study

The current crisis of the COVID-19 pandemic around the world has been devastating as many lives have been lost to the novel SARS CoV-2 virus. Thus, there is an urgent need for the right therapeutic drug to curb the disease. However, there is time constraint in drug development, hence the need for dr...

Celý popis

Uloženo v:
Hlavní autoři: Alfred Olaoluwa Akinlalu, Annapoorna Chamundi, Donald Terseer Yakumbur, Funmilayo I. Deborah Afolayan, Ijeoma Akunna Duru, Michael Aderibigbe Arowosegbe, Ojochenemi Aladi Enejoh
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021-09-01
Edice:Scientific African
Témata:
Drug repurposing
COVID-19
In silico methods
Target-based docking
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2468227621001496
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky